Clinical Pathways

  • CMO Dr. Andrew Hertler Reacts to the FDA's Recent ODAC Meeting

    CMO Dr. Andrew Hertler Reacts to the FDA's Recent ODAC Meeting

    New Century Health CMO, Dr. Andrew Hertler, shares his thoughts on the recent FDA meetings to review the merits of approved cancer drugs.

    Watch Video
  • Traditional UM Programs Can't Move the Needle in Cardiology Care. Here's What Does.

    Traditional UM Programs Can't Move the Needle in Cardiology Care. Here's What Does.

    Senior Medical Director Fernando Villacian lays out the key tenets of an effective cardiovascular management program.

    Read Article
  • ×

    First Name
    Last Name
    Company Name
    Thank you!
    Error - something went wrong!
  • Episode 2: Choice Paralysis

    Episode 2: Choice Paralysis

    The therapeutic landscape in oncology is vast and everchanging, marked by a dramatic pace of innovation and new approvals. In this complicated specialty, how can payers and providers keep up?

    Read Article
  • Introduction to Leading Causes: A Podcast by New Century Health

    Introduction to Leading Causes: A Podcast by New Century Health

    In this podcast series we explore the trends and forces behind the two leading causes of death in the United States: cancer and heart disease.

    Listen to Podcast
  • Let's Go
  • Cardiovascular Clinical Pathways Program at New Century Health

    Cardiovascular Clinical Pathways Program at New Century Health

    Our senior medical director speaks with Journal of Clinical Pathways about preventing inappropriate use in cardiology.

    Read External Article
  • Can Clinical Pathways Help Combat Health Care Disparities?

    Can Clinical Pathways Help Combat Health Care Disparities?

    A new research effort aims to gauge whether certain groups of patients receive high-value therapies at lower rates than others.

    Read Article
  • Pathways, Portals and Persuasion: Reining in an Overused Cancer Agent

    Pathways, Portals and Persuasion: Reining in an Overused Cancer Agent

    NCH's approach to more appropriate use of myeloid growth factor provides a playbook for how to change prescribing patterns.

    Read Article
  • How Real-World Evidence Can Transform High-Value Oncology Pathways

    How Real-World Evidence Can Transform High-Value Oncology Pathways

    Our CMO Dr. Andrew Hertler explains how real world evidence may usher in the next generation of clinical oncology pathways.

    Read Article
  • High-Value Clinical Pathways Help Illinois Cancer Practice Reduce Drug Spend

    High-Value Clinical Pathways Help Illinois Cancer Practice Reduce Drug Spend

    Recent journal article details how NCH and Cancer Care Specialists of Illinois teamed up to slow growth in drug spend.

    Read Article
  • How Clinical Pathways Are Growing

    How Clinical Pathways Are Growing

    Increasing use of real-world evidence is one of the most exciting trends in pathway development, our CMO tells Journal of Clinical Pathways.

    Read External Article
  • Learn More
  • Clinical Pathways Slow Drug Spending in Community Oncology

    Clinical Pathways Slow Drug Spending in Community Oncology

    Medscape delves into our work with a community oncology practice to implement high-value clinical pathways and engage providers

    Read External Article
  • New Century Health Pathways Help Community Practice Reduce Drug Spending

    New Century Health Pathways Help Community Practice Reduce Drug Spending

    Our chief medical officer, Dr. Andrew Hertler, speaks with Journal of Clinical Pathways about our approach to high-value cancer care.

    Read External Article
  • Illinois Practice Shows Empowering Oncologists Can Reduce Cancer Drug Spend

    Illinois Practice Shows Empowering Oncologists Can Reduce Cancer Drug Spend

    Cancer Care Specialists of Illinois reduced drug spend by 13.5% compared to peer practices by deploying our care pathway and physician collaboration protocols

    Read Press Release
  • Partnership and Pathways Drive Success in the Oncology Care Model

    Partnership and Pathways Drive Success in the Oncology Care Model

    Navigating the CMS Oncology Care Model can be complicated. Listen to oncologist Dr. Wade describe his OCM experiences and how a partnership with New Century Health positioned his practice for success.

    Watch Video
  • Learn More
  • Lower Patient Costs Doesn’t Have to Mean Lower Profits

    Lower Patient Costs Doesn’t Have to Mean Lower Profits

    As the pace of treatment innovation threatens the financial health of both patients and oncology practices, it’s time to redefine reimbursement models to care for both financial and physical outcomes.

    Read External Article
  • Are You Ready for the Next Wave of Specialty Care Management?

    Are You Ready for the Next Wave of Specialty Care Management?

    Dr. Andrew Hertler, Chief Medical Officer at New Century Health, explains how value-based arrangements lower the cost of specialty care while providing higher-quality treatment for patients.

    Learn More
  • Cancer Care Costs Everyone Too Much. Here's How We Fix It.

    Cancer Care Costs Everyone Too Much. Here's How We Fix It.

    Dr. Andrew Hertler, Chief Medical Officer at New Century Health, demonstrates how clinical pathways improve patient outcomes while decreasing waste and cost.

    Read Article
  • loading
    Loading More...